Cogent Biosciences, Inc.COGTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-329M

-28.6% YoY

Free Cash Flow

$-266M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.3B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-5
Operating Income	-76	-148↓95.7%	-208↓40.8%	-276↓32.6%	-333↓20.8%
Net Income	-72	-140↓94.0%	-192↓37.2%	-256↓33.0%	-329↓28.6%
EBITDA	-74	-142↓93.0%	-205↓44.1%	-272↓32.8%	-329↓21.0%
EPS Diluted	-1.85	-2.26↓22.2%	-2.42↓7.1%	-2.46↓1.7%	-2.55↓3.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	220	140↓36.3%	53↓61.9%	98↑84.4%	312↑217.8%
Total Current Assets	223	265↑19.0%	271↑2.2%	296↑9.5%	910↑207.1%
Total Assets	232	301↑29.6%	313↑4.2%	328↑4.6%	938↑185.9%
Total Current Liabilities	17	27↑57.2%	38↑42.2%	56↑46.0%	64↑14.8%
Total Liabilities	18	45↑151.7%	56↑23.4%	72↑28.7%	301↑320.7%
Total Equity	214	256↑19.4%	258↑0.8%	256↓0.6%	636↑148.3%
Total Debt	3	20↑522.8%	19↓4.1%	17↓7.4%	253↑1349.3%
Net Debt	-217	-120↑44.5%	-34↑71.4%	-81↓134.8%	-59↑27.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-59	-119↓101.9%	-154↓29.5%	-208↓35.3%	-264↓27.3%
Capital Expenditure	-2	-7↓299.2%	-3↑59.3%	-1↑79.5%	-2↓171.2%
Free Cash Flow	-60	-126↓107.5%	-156↓24.6%	-208↓33.2%	-266↓27.7%
Stock-Based Comp	12	18↑57.2%	31↑66.7%	40↑29.8%	46↑16.0%
Net Change in Cash	-23	-80↓254.6%	-88↓10.2%	45↑151.1%	214↑376.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance